Related references
Note: Only part of the references are listed.Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data
Deanna E. Morra et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis
Martijn J. H. Doeleman et al.
RHEUMATOLOGY (2019)
Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
Sakiko Tabata et al.
INTERNAL MEDICINE (2019)
The full spectrum of Castleman disease: 273 patients studied over 20 years
Eric Oksenhendler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease
David C. Fajgenbaum et al.
BLOOD (2017)
Adverse events of glucocorticoids during treatment of rheumatoid arthritis: lessons from cohort and registry studies
Johannes W. J. Bijlsma et al.
RHEUMATOLOGY (2016)
Idiopathic multicentric Castleman's disease: a systematic literature review
Amy Y. Liu et al.
LANCET HAEMATOLOGY (2016)
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Frits van Rhee et al.
LANCET ONCOLOGY (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Clinical Features and Treatment of Multicentric Castleman's Disease : A Retrospective Study of 21 Japanese Patients at a Single Institute
Hiroshi Kawabata et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2013)
Surgery in Castleman's Disease A Systematic Review of 404 Published Cases
Nadia Talat et al.
ANNALS OF SURGERY (2012)
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease
Mark Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus-associated multicentric Castleman's disease:: ANRS 117 CastlemaB trial
Laurence Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
N Nishimoto et al.
BLOOD (2005)